Trump spares drugmakers from tariffs; costs could still go up

President Trump spared pharmaceuticals from the opening salvo in his campaign to transform the economy through “reciprocal” tariffs; however, the global drug market may still be hit by reverberations from trade wars. The White House listed pharmaceuticals as exempted from the tariffs in Trump’s order signed Wednesday and set to take effect Saturday. Other exempted...